Navigation Links
Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
Date:4/20/2011

xes18165

(k)251

(m)25367

(k)3205

(l)Net income$ 1,125$ 133$
,258$ 1,167$ 115$
,282Earnings per share:Basic$   1.21$
.35$   1.19$
.31Diluted (n)$   1.20$
.34

(a)$   1.18$
.30

(a)Average shares used in calculationof earnings per share:Basic933933982982Diluted (n)941940

(a)988988

(a)(a) - (n)

See explanatory notes on the following pages.Amgen Inc.Notes to Reconciliation of GAAP Earnings to "Adjusted" Earnings(In millions, except per share data)(Unaudited) (a) To exclude stock option expense. For the three months ended March 31, 2011 and 2010, the total pre-tax expense for employee stockoptions was $22 million and $27 million, respectively."Adjusted" diluted EPS including the impact of stock option expense for the three months ended March 31, 2011 and 2010 were as follows: Three months endedMarch 31, 20112010"Adjusted" diluted EPS, excluding stock option expense

$
.34$
.30Impact of stock option expense (net of tax)

(0.02)(0.02)"Adjusted" diluted EPS, including stock option expense

$
.32$
.28 (b) To exclude accelerated depreciation for manufacturing assets resulting from our transaction with Boehringer Ingelheim (BI) involvingour manufacturing operations in Fremont, California (the BI Fremont transaction).  The amount reflected above representsthe incremental depreciation expense over the amount that would have otherwise been incurred absent the BI Fremont transaction.This transaction was entered into as part of our ongoing efforts to optimize our network of manufacturing facilities and improve costs efficiencies. (c) To exclude loss accruals for certain facility operating leases associated with the BI Fremont transaction that will not be used in our business. (d) To exclude the ongoing, non-cash amortization of the research and development (R&D) technology intangible assets with alternative futureuses acq
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
2. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
3. Cepheid Reports 2011 First Quarter Results
4. ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
5. Caliper Life Sciences First Quarter Results Conference Call Notice
6. Siemens Applauds First Health System Customers to Successfully Attest to Meaningful Use
7. Cardiogenesis Corporation to Report 2011 First Quarter Results on May 4th
8. PDL BioPharma to Announce First Quarter 2011 Financial Results on April 27, 2011
9. WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release
10. Masimo to Report First Quarter 2011 Financial Results After Market Close on May 3, 2011
11. MiMedx Group, Inc. Announces Release Date for First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... privately held medical device company, announced today that it ... Corporation (Tokyo Stock Exchange TYO: 8001) to sell its ... in Japan . ViewRay,s technology, the ... MRI-guided radiation therapy system that images and treats cancer ...
(Date:1/22/2015)...  Amgen (NASDAQ: AMGN ) today announced that it will ... Tuesday, Jan. 27, 2015, after the close of the U.S. financial ... the investment community at 2 p.m. PT. Participating in the call ... chief executive officer, and other members of Amgen,s senior management team. ...
(Date:1/22/2015)... 22, 2015 Research and Markets ( ... "Microbiology Testing/Clinical Microbiology Market by Product, Clinical ... 2019" report to their offering. ... techniques for the detection of infectious diseases. The ...
Breaking Medicine Technology:ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 3
... Adeona Pharmaceuticals, Inc. (AMEX: AEN ), a ... reported its second quarter 2011 financial results for the period ended ... the second quarter. Updates since the beginning of ... Multiple Sclerosis (MS) ...
... Aug. 15, 2011 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTCBB: ... and seller of medicine and drugs in the People,s ... for the quarter ended June 30, 2011. Summary financial ... Quarter Financial Highlights Revenues for ...
Cached Medicine Technology:Adeona Reports Second Quarter 2011 Financial Results 2Adeona Reports Second Quarter 2011 Financial Results 3Adeona Reports Second Quarter 2011 Financial Results 4Adeona Reports Second Quarter 2011 Financial Results 5Adeona Reports Second Quarter 2011 Financial Results 6Adeona Reports Second Quarter 2011 Financial Results 7Adeona Reports Second Quarter 2011 Financial Results 8Adeona Reports Second Quarter 2011 Financial Results 9Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 2Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 3Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 4Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 5Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 6Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 7
(Date:1/22/2015)... 22, 2015 Carinsurancesavings.biz has released a new ... and dismemberment insurance . , Purchasing an accidental death ... very advantageous. This type of rider provides benefits if the ... be considered a lesser form of life insurance. , ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Recently, Weddingshe.com has ... catalog, and has announced its highest annual revenues in the ... on its popular glamorous wedding dresses. , According to the ... important wedding dress promotions for them in 2015. This point ...
(Date:1/22/2015)... Four years since the release of their debut recording Love is ... Avasa & Matthew Love – the duo are pleased to announce ... White Swan Records on February 24, 2015. , THE ROAD offers ... to all of us to walk out of the mire of ...
(Date:1/22/2015)... January 22, 2015 EBSCO Information Services ... are expanding their relationship in an effort to further promote ... world. While EBSCO has long made AMA journals available via ... agent for The JAMA Network. , Long known ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... (CRT) for head and neck cancer, performing targeted swallowing ... swallowing function; however, there were no significant differences in ... nine or 12 months following treatment, according to a ... Otolaryngology Head & Neck Surgery , a JAMA ...
... , MONDAY, April 16 (HealthDay News) -- Tattoos and body ... trend in western societies, but a new study in France ... alcohol than their peers. In the study, researchers ... as they left bars and other drinking establishments. The readings ...
... , MONDAY, April 16 (HealthDay News) -- New long-term research ... in heart arteries. Reporting in the April 16 issue ... study has shown the biodegradable Igaki-Tamai stent, made of a ... foreign material in an artery and reducing the occurrence of ...
... (HealthDay News) -- Media multitasking -- the use of more ... time -- may have some positive effects, a new study ... -- which is especially common in young people and could ... games or social networking -- have received widespread publicity. ...
... 16, 2012) Columbia University Medical Center (CUMC) scientists ... (PI3K) gamma and delta play a key role ... a highly aggressive childhood leukemia that is difficult to ... gamma/delta inhibitor can significantly prolong survival in a mouse ...
... should be possible to significantly improve the response of ... at Cold Spring Harbor Laboratory (CSHL), by introducing agents ... immediate surroundings, called the tumor microenvironment. In research ... , CSHL Assistant Professor Mikala Egeblad and her team ...
Cached Medicine News:Health News:Swallowing exercises linked with short-term improvement among patients with head and neck cancer 2Health News:Tattoos, Piercings Tied to Heavier Drinking in French Study 2Health News:Dissolvable Heart Artery Stents Appear Safe in Study 2Health News:Media Multitasking Might Have Mental Upside 2Health News:Study identifies potential treatment for lethal childhood leukemia 2Health News:Study identifies potential treatment for lethal childhood leukemia 3Health News:Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment 2Health News:Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment 3
Blunt tipped forceps wlth a small grasping platform on each tip. For grasping fine membranes or grasping membranes adherent to the retinal surface....
Blunt tipped forceps with a smooth, pliable silicone coating on the entire interior surface of the tip. For removal of foreign bodies or atraumatic tissue grasping....
Blunt tipped forceps with small, slightly rounded tips angled perpendicular to the shaft. For grasping peripheral membranes....
Blunt tipped forceps with small, slightly pointed grasping platforms on each tip. For general purpose (fine) membrane grasping and grasping membranes adherent to the retlnal surface....
Medicine Products: